Literature DB >> 14991619

Ectopic T cell receptor expression causes B cell immunodeficiency in transgenic mice.

Adrian A Lobito1,2, Marcela F Lopes1, Michael J Lenardo1.   

Abstract

Mice expressing transgenic T cell receptors (TCR) are used to explore important questions in immunity. However, transgene expression may have unexpected effects. We previously reported a B cell immunodeficiency, comprising decreased B cell numbers and diminished antibody responses, in mice that express a transgenic TCR specific for nicotinic acetylcholine receptor; the mice were generated using cassette vectors designed specifically for transgenic TCR expression [see Kouskoff et al. J. Immunol. Methods 1995. 180: 273-280]. We now show data suggesting that this defect is due to the expression and accumulation of TCR alpha and beta chains inside B cells and induction of an endoplasmic reticulum stress response, causing apoptosis at the pre B-I and later B cell stage. Thus, inappropriate transgene expression can profoundly affect B cells, leading to a previously undescribed mechanism of immunodeficiency.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991619     DOI: 10.1002/eji.200324675

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  2 in total

1.  Ectopic T cell receptor-α locus control region activity in B cells is suppressed by direct linkage to two flanking genes at once.

Authors:  Stefan Knirr; Janette Gomos-Klein; Blanca E Andino; Faith Harrow; Karl F Erhard; Damian Kovalovsky; Derek B Sant'Angelo; Benjamin D Ortiz
Journal:  PLoS One       Date:  2010-11-22       Impact factor: 3.240

2.  Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1157-165 tumor-specific peptide.

Authors:  Eugene Shenderov; Matheswaran Kandasamy; Uzi Gileadi; Jili Chen; Dawn Shepherd; James Gibbs; Gennaro Prota; Jonathan D Silk; Jonathan W Yewdell; Vincenzo Cerundolo
Journal:  J Immunother Cancer       Date:  2021-06       Impact factor: 13.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.